In Vivo Longitudinal Tracking of Lymphangiogenesis and Angiogenesis in Cutaneous Melanoma Mouse Model Using Multifunctional Optical Coherence Tomography

• Published in: JID innovations Vol. 1; no. 2; p. 100010
• Main Authors: Lai, Pei-Yu, Shih, Tai-Yu, Chang, Yu-Huan, Chou, Ya-Shuan, Wu, Ting-Hua, Su, Yu-Ya, Chang, Chung-Hsing, Kuo, Wen-Chuan
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.06.2021; Elsevier
• Subjects: Original; 3D; CT; OCT; LN; MFOCT; 4-HT; PET; MFOCT, multifunctional optical coherence tomography; 3D, three-dimensional; PET, positron emission tomography; 4-HT, (Z)-4-hydroxytamoxifen; OCT, optical coherence tomography; CT, computed tomography; LN, lymph node
• ISSN: 2667-0267; 2667-0267
• DOI: 10.1016/j.xjidi.2021.100010

Melanoma is a high-risk skin cancer because it tends to metastasize early and ultimately leads to death. In this study, we introduced a noninvasive multifunctional optical coherence tomography (MFOCT) for the early detection of premetastatic pathogenesis in cutaneous melanoma by label-free imaging of microstructures (i.e., providing the thickness and the scattering information) and microcirculation (i.e., providing depth-resolved angiography and lymphangiography). Using MFOCT-based approaches, we presented an in vivo longitudinal observation of the tumor microenvironment in BrafV600E/V600E;Pten−/− mice with inducible melanoma monitored for 42 days. Quantitative analysis of MFOCT images identified an increased number of lymphatic and vascular vessels during tumor progression and faster lymphangiogenesis (beginning on day 21) than angiogenesis (beginning on day 28) in the melanoma microenvironment. We further observed lymphatic vessel enlargement from the first week of melanoma development, implying tumor cells interacting with the vessels and increased likelihood of metastasis. MFOCT identified cutaneous melanoma‒associated angiogenesis and lymphangiogenesis before the possible visual perception of the tumor (≥42 days) and before metastasis could be diagnosed using micropositron emission tomography (35 days). Thus, the proposed quantitative analysis using MFOCT has the potential for early detection of cutaneous melanoma progression or prediction of metastatic melanoma in a mouse model. However, retrospective and extensive experiments still need to be performed in the future to confirm the value of MFOCT in clinical application.